Pliant Therapeutics, Inc.
PLRX
$1.48
$0.010.68%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 13.90% | -3.42% | -18.95% | -14.22% | 0.91% |
| Total Depreciation and Amortization | -13.91% | -14.47% | 21.25% | 10.56% | 3.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.55% | -8.05% | 1.83% | -23.41% | 105.82% |
| Change in Net Operating Assets | -157.41% | 932.30% | -136.17% | 677.18% | 124.95% |
| Cash from Operations | -47.68% | 28.75% | -49.64% | -20.59% | 30.70% |
| Capital Expenditure | 76.67% | 28.38% | 16.15% | -2,345.90% | 35.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 23.50% | 166.51% | -80.42% | 90.85% | -16.60% |
| Cash from Investing | 26.40% | 189.29% | -82.03% | 86.54% | -16.55% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -81.40% | -20.61% | -63.60% | 709.91% | -70.03% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 82.67% |
| Cash from Financing | -81.22% | -20.61% | -96.86% | 9,848.86% | -68.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -994.55% | 97.73% | -166.41% | 625.53% | 157.99% |